Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer. - Wikidata - awgldk - TriplyDB

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

http://www.wikidata.org/entity/Q34502198

about

Asap: a framework for over-representation statistics for transcription factor binding sites Aberrant DNA methylation of OLIG1, a novel prognostic factor in non-small cell lung cancer The histone demethylase Jhdm1a regulates hepatic gluconeogenesis Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1 Enriched transcription factor binding sites in hypermethylated gene promoters in drug resistant cancer cells VILIP-1 downregulation in non-small cell lung carcinomas: mechanisms and prediction of survival.AP-2alpha induces epigenetic silencing of tumor suppressive genes and microsatellite instability in head and neck squamous cell carcinoma Identification of a myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia.CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression.C/EBPδ gene targets in human keratinocytes.HOXB13, a target of DNMT3B, is methylated at an upstream CpG island, and functions as a tumor suppressor in primary colorectal tumors.Identification of C/EBPα as a novel target of the HPV8 E6 protein regulating miR-203 in human keratinocytes.CARM1 is required for proper control of proliferation and differentiation of pulmonary epithelial cells Genome-wide epigenetic analysis delineates a biologically distinct immature acute leukemia with myeloid/T-lymphoid features.Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases CCAAT/enhancer-binding protein-α suppresses lung tumor development in mice through the p38α MAP kinase pathway.The CEBPA gene is down-regulated in acute promyelocytic leukemia and its upstream promoter, but not the core promoter, is highly methylated Germline and somatic DNA methylation and epigenetic regulation of KILLIN in renal cell carcinoma.Expression of the mismatch repair gene hMLH1 is enhanced in non-small cell lung cancer with EGFR mutations CCAAT/enhancer binding protein β is dispensable for development of lung adenocarcinoma.Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations Oxidative stress induced lung cancer and COPD: opportunities for epigenetic therapy.Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing.Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.Distinct gene expression profiles of acute myeloid/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1.Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance The significance of epigenetic alterations in lung carcinogenesis.Deficiency of CCAAT/enhancer binding protein family DNA binding prevents malignant conversion of adenoma to carcinoma in NNK-induced lung carcinogenesis in the mouse Germline epigenetic regulation of KILLIN in Cowden and Cowden-like syndrome.Dysregulation of the C/EBPalpha differentiation pathway in human cancer.Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex.Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.Activator protein 2 alpha (AP2alpha) suppresses 42 kDa C/CAAT enhancer binding protein alpha (p42(C/EBPalpha)) in head and neck squamous cell carcinoma.C/EBPalpha expression is partially regulated by C/EBPbeta in response to DNA damage and C/EBPalpha-deficient fibroblasts display an impaired G1 checkpoint DNMT1-interacting RNAs block gene-specific DNA methylation.MicroRNA dysregulation in gastric cancer: a new player enters the game.15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer.The role of CCAAT/enhancer binding protein (C/EBP)-alpha in osteogenesis of C3H10T1/2 cells induced by BMP-2.Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.

P2860

Q21092224-FC4F8A7A-E6EF-4100-8228-76C8BB745985 Q21092374-712A64D3-83FC-4CDD-B049-AD3F32B5E1A6 Q21144913-CF5D89EF-A9E2-4C35-A133-7C085AD9B911 Q24652017-F80100D4-AE50-4C82-8EE1-23AF8AD9FB8A Q24655144-5FDA7546-F85F-47D2-8D67-C3058B42729C Q28390582-BC25045F-D321-49E2-9F56-8C9EB0957261 Q33321264-AF24DC37-BFD7-486B-93ED-BC2EDB2BBE94 Q33501737-7FB10A54-6C7C-4B2E-AA36-7155CB775802 Q33560404-3150FC46-DAE9-435C-B5F1-F84736478668 Q33726245-BFB1EA23-4E31-4ADC-A110-97E3F88FDF38 Q33745060-D42FC4DE-32E6-4362-828B-EA8AB67A5C88 Q33818402-EE06BF9C-FE46-4C81-827C-47A5E854705E Q33825575-C4B6BD75-F722-47C2-A2F5-F03E66FF3EC3 Q33899490-CA013EE4-65DF-4589-9939-3F290680CE5E Q34156717-D2001F78-C424-43DF-B53D-D182501A5588 Q34577037-D232FE51-F216-4464-971B-36FE72C9C193 Q34599904-5FD91049-B144-41D5-A445-FD1028CDBF7F Q34750625-37E88BD8-78EB-426B-A3F4-D9DC86D8A22C Q35032574-4E064BB0-5DF9-41D9-8210-924D540CD411 Q35036471-96599293-56AC-4C1B-A94B-6E44855950EC Q35175264-8B94B042-2F40-4305-A449-59699F875DCC Q35597950-102B7627-8B72-4A5E-8D1E-6E682FB84251 Q35841917-A307FF3F-237D-4DBA-8DAD-2096D2FAC011 Q36010758-8411F997-2613-4757-89F0-8F6B3EAD63DD Q36049618-D6D8D202-0B77-4012-9DFE-736C28851CF8 Q36141686-0D3BBAA4-5DEB-4FB7-8D69-52F0B29B07BE Q36449835-46EA1DA7-0401-436F-9382-A005129B6BD3 Q36457427-FE81C654-63C7-4AAC-9447-3861954C5AA1 Q36544436-12A7CCEA-5FEF-4BB7-B646-184E90A06503 Q36847856-787886DD-5E37-4261-A022-3C0202DE1D25 Q37104787-1980B6CA-1AF2-4C35-BAB8-2E8F685B1D20 Q37142723-309F8A8A-16DD-44EB-8511-F821E5C6551A Q37170593-706447F9-EE1D-41ED-A19B-13A8257A547B Q37177505-CF577371-DFC3-4822-8C9E-17BCC4B276D2 Q37341405-984ADF29-709D-435C-9393-357E2037DBC8 Q37408576-BFBF73A3-D540-46F4-A502-6F7A007F2AE3 Q37783909-8566F8F7-719F-45A5-A8D2-A209053FF6DC Q38289660-3975D592-8F99-439A-91E2-DECF12FBE041 Q38357733-3C542D96-6C98-43B8-8244-9604341F812D Q38358635-66DAAF16-4A98-484D-9382-305E97B587BD

P2860

Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.

http://www.wikidata.org/entity/Q34502198

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@ast

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@en

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@nl

type

label

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@ast

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@en

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@nl

prefLabel

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@ast

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@en

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@nl

P1433

Q34502198-CC8EB349-3683-4501-AB32-76D9B695D1B7

P1476

Q34502198-E2AC5BA5-B52E-4558-9655-E433F7AF96C6

P2093

Q34502198-35D12DAC-6438-4073-9534-ED3AB499AB4A

Q34502198-6F202492-5F92-4654-A43C-E5F32DF21646

Q34502198-7BA112BE-8FAD-42AC-A754-15A53F585AD6

Q34502198-A83941E3-3321-473F-9E9E-C0F5A2440639

Q34502198-BA58956D-B03F-4946-A7AB-759F4EAF34D3

Q34502198-E6E6F169-AD2F-421B-B495-534AD2C6C2EF

P2860

Q34502198-03774EE6-F663-4812-91DC-0ECD146FC95B

Q34502198-0894D973-921B-4AA9-85DD-7362DFC9C1D1

Q34502198-0CAFA05E-CE42-48F6-818E-92D499FB9A75

Q34502198-0DFAD16F-1833-44E5-A353-94365B660C5F

Q34502198-1191D944-E515-4815-9B23-BDF397AC02A7

Q34502198-16295DFF-D457-40BE-A3DE-1E06D45F7836

Q34502198-3101B66E-853E-4301-8422-523781B77743

Q34502198-3F146739-7BF2-450C-9161-C6527A6FB182

Q34502198-478890E2-DF99-4FB2-866C-FB5953B41D2D

Q34502198-4DBADD44-0F17-4821-BC4A-0C6B1EB66352

P304

Q34502198-F822B4CA-9465-41B6-A26A-CD390E3A93BD

P31

Q34502198-AA3E69C2-A126-47A1-87CD-21E04DF01C50

P356

Q34502198-4443C3F0-0B00-4474-B375-8D7749B91B13

P407

Q34502198-484AF548-650C-4315-A035-3749017E7BD6

P433

Q34502198-B39D3A3F-37E2-47F4-9DC1-32506AE05377

P478

Q34502198-D953D2AA-EB2C-43FF-B64A-D4A277EF3CF3

P577

Q34502198-EBE0879C-E4BB-4A88-9266-00F9A6F0654E

P5875

Q34502198-8A88BCA1-8D13-4F27-A8B9-B4B866DAFCEA

P698

Q34502198-B6F49EAC-6F84-49C7-8E56-C3286C906640

P356

P1433

Journal of the National Cancer Institute

P1476

Epigenetic modulation of tumor ...... alpha activity in lung cancer.

@en

P2093

Björn Hackanson

http://www.w3.org/2001/XMLSchema#string

Carl Morrison

http://www.w3.org/2001/XMLSchema#string

Christoph Plass

http://www.w3.org/2001/XMLSchema#string

Gregory A Otterson

http://www.w3.org/2001/XMLSchema#string

Romulo Martin Brena

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Tada

http://www.w3.org/2001/XMLSchema#string

P2860

Comprehensive analysis of CpG islands in human chromosomes 21 and 22

A component of the transcriptional repressor MeCP1 shares a motif with DNA methyltransferase and HRX proteins

Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer

CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer

Increased hepatic cell proliferation and lung abnormalities in mice deficient in CCAAT/enhancer binding protein alpha

Epigenetics in human disease and prospects for epigenetic therapy

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

Methylation-induced repression--belts, braces, and chromatin

A new tool for the rapid cloning of amplified and hypermethylated human DNA sequences from restriction landmark genome scanning gels.

Lung cancer. 9: Molecular biology of lung cancer: clinical implications.

P304

396-406

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJJ093

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7240461

http://www.w3.org/2001/XMLSchema#string

P698

16537832

http://www.w3.org/2001/XMLSchema#string